Hologene 17 (ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a COL17A1-encoding retroviral vector) / Holostem - LARVOL DELTA

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17) (clinicaltrials.gov) - P1/2 | N=1 | Terminated | Sponsor: Holostem Terapie Avanzate s.r.l. | Active, not recruiting ➔ Terminated; No patient ongoing (none completed the study). Changes to the viral vector ongoing.

Trial termination